BiologicalDrug
TroVax clinical trials
Also written TroVax.
- studies test it
- 9
- open now
- 0
- in phase 3
- 1
- first study started
- 2004
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
8 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 5
Oxford BioMedica (4) · University College, London (1) · Cancer Research UK (1) · The Methodist Hospital Research Institute (1) · Wales Cancer Trials Unit (1) · SWOG Cancer Research Network (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses TroVax is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell CancerCompletedPhase 2Oxford BioMedicaNCT00083941Written as TroVax
- Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell CarcinomaCompletedPhase 2Oxford BioMedicaNCT00325507Written as TroVax
- TroVax Renal Immunotherapy Survival TrialCompletedPhase 3Oxford BioMedicaNCT00397345Written as Trovax
- TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)TerminatedPhase 2Oxford BioMedicaNCT01194960Written as TroVax
- The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian CancerCompletedPhase 2University College, LondonNCT01556841Written as TroVax®
- Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate CancerTerminatedPhase 2The Methodist Hospital Research InstituteNCT00521274Written as MVA 5T4
- A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaStatus unknownPhase 2Wales Cancer Trials UnitNCT01569919Written as TroVax®
- S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in RemissionWithdrawnPhase 2SWOG Cancer Research NetworkNCT00227474Written as recombinant modified vaccinia Ankara-5T4 vaccine
- Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases RemovedCompletedPhase 2Cancer Research UKNCT00259844Written as TroVax
Given in every arm · 2 — TroVax is usual care beside what is tested
- Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal CancerCompletedPhase 2The Methodist Hospital Research InstituteNCT00445523Written as TroVax® (Immunological Vaccine Therapy)
- Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate CancerCompletedPhase 2The Methodist Hospital Research InstituteNCT00448409Written as TroVax